Finerenone, an oral medication approved for diabetes-related chronic kidney disease, may reduce urine protein levels and stabilize kidney function in adults with immunoglobulin A nephropathy (IgAN). That’s according to a one-year real-world study in China, which also showed benefits among participants who were not receiving immunosuppressive therapy, as well as…
News
Immunoglobulin A nephropathy (IgAN) shares genetic risk factors with many cardiovascular and metabolic conditions, a study found. The findings may help explain why people with IgAN are at high risk of health complications such as heart disease, researchers said. Based on these shared genetic profiles, they identified several existing medications…